🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and activity in the ...
Status
Completed
Location
Arensia Clinical Research Unit
Start Date
2019-08-14
Trial ID
NCT04073498
This study is aimed to evaluate the progression-free survival(PFS) and also...
Status
Unknown
Location
The First Affiliated Hospital of AnHui Medical University
Start Date
2015-02
Trial ID
NCT02348450
Treatments Being Tested
This is a single-arm, phase II study aiming to evaluate the feasibility and...
Status
Unknown
Location
Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital
Start Date
2019-05-01
Trial ID
NCT04267549
Treatments Being Tested
This is a phase I/II, open-label, dose escalation and dose extension study ...
Status
Terminated
Location
Shanghai East Hospital
Start Date
2021-05-20
Trial ID
NCT04882176
Treatments Being Tested
A key strategy in the treatment of COVID-19 would be to find an effective a...
Status
Completed
Location
Hospital do Coracao
Start Date
2021-02-15
Trial ID
NCT04468087
Pemphigus vulgaris (PV) is a rare, chronic, debilitating, and potentially l...
Status
Unknown
Location
Tongji Hospital
Start Date
2021-02-01
Trial ID
NCT05303272
Treatments Being Tested
This study evaluates the efficacy, safety and pharmacokinetics of tinostamu...
Status
Completed
Location
Mayo Clinic
Start Date
2016-04-14
Trial ID
NCT02576496
Treatments Being Tested
The purpose of this study is to allow continued use of pasireotide in patie...
Status
Completed
Location
Ximed Research SC - SOM230B2412
Start Date
2013-06-10
Trial ID
NCT01794793
Treatments Being Tested
The primary objective for this study is to assess the safety and tolerabili...
Status
Completed
Location
USC Norris Cancer Center
Start Date
2016-03-09
Trial ID
NCT02670044
Treatments Being Tested
First-in-human, single centre, two parts, dose-escalation, parallel-group, ...
Status
Recruiting
Location
CROSS Research S.A. Phase I Unit
Start Date
2024-12-04
Trial ID
NCT06705998
Treatments Being Tested